XTX Topco Ltd Purchases New Holdings in agilon health, inc. (NYSE:AGL)

XTX Topco Ltd purchased a new position in shares of agilon health, inc. (NYSE:AGLFree Report) during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 32,266 shares of the company’s stock, valued at approximately $211,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Norges Bank bought a new stake in agilon health during the fourth quarter worth $27,902,000. Nomura Asset Management Co. Ltd. raised its holdings in shares of agilon health by 31.5% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 8,969 shares of the company’s stock valued at $113,000 after purchasing an additional 2,149 shares during the period. Scotia Capital Inc. lifted its stake in agilon health by 1.3% in the 4th quarter. Scotia Capital Inc. now owns 132,576 shares of the company’s stock valued at $1,664,000 after purchasing an additional 1,741 shares during the last quarter. Bank of Nova Scotia bought a new position in agilon health during the fourth quarter worth about $305,000. Finally, Capital International Investors increased its position in agilon health by 16.2% during the fourth quarter. Capital International Investors now owns 10,934,636 shares of the company’s stock worth $137,230,000 after buying an additional 1,521,995 shares during the last quarter.

Analysts Set New Price Targets

AGL has been the subject of several research analyst reports. Evercore ISI lifted their target price on agilon health from $5.50 to $7.00 and gave the stock an “in-line” rating in a research note on Tuesday, July 9th. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of agilon health from $5.00 to $4.00 and set a “hold” rating on the stock in a report on Friday, August 9th. Royal Bank of Canada restated an “outperform” rating and set a $8.00 target price on shares of agilon health in a research note on Wednesday, August 7th. Finally, Benchmark reiterated a “buy” rating and issued a $9.00 price target on shares of agilon health in a research note on Thursday, August 8th. One research analyst has rated the stock with a sell rating, fourteen have given a hold rating and four have given a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $8.57.

View Our Latest Report on agilon health

agilon health Trading Up 0.3 %

AGL opened at $3.74 on Monday. The stock has a market capitalization of $1.54 billion, a price-to-earnings ratio of -5.34 and a beta of 0.54. The company has a quick ratio of 1.36, a current ratio of 1.36 and a debt-to-equity ratio of 0.04. agilon health, inc. has a twelve month low of $3.07 and a twelve month high of $20.37. The company has a 50-day simple moving average of $4.83 and a 200 day simple moving average of $5.45.

agilon health (NYSE:AGLGet Free Report) last posted its quarterly earnings results on Tuesday, August 6th. The company reported ($0.07) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.07). agilon health had a negative net margin of 5.57% and a negative return on equity of 29.91%. The business had revenue of $1.48 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same quarter last year, the business posted ($0.04) EPS. The firm’s revenue for the quarter was up 38.7% on a year-over-year basis. Analysts predict that agilon health, inc. will post -0.32 EPS for the current fiscal year.

Insider Activity

In other agilon health news, CEO Steven Sell acquired 20,000 shares of the company’s stock in a transaction that occurred on Thursday, September 12th. The stock was acquired at an average cost of $3.36 per share, for a total transaction of $67,200.00. Following the transaction, the chief executive officer now directly owns 67,590 shares in the company, valued at $227,102.40. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 3.20% of the company’s stock.

agilon health Company Profile

(Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Read More

Institutional Ownership by Quarter for agilon health (NYSE:AGL)

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.